EXOZ EXOZYMES INC.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $35.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $22.0K | $0 |
| 2025-Q1 | $20.3K | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $10.6K | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $15.4K |
| 2026-Q3 | $6.4K | $0 |
| 2026-Q4 | $0 | $19.4K |
Bought$59.4K6 buy days
Sold$34.9K3 sell days
Net insider flow+$24.5Knet buying · 5 years
Latest trade2026-10-12Perriman Damien Alan
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Sell | Perriman Damien Alan | Other C-suite | 3,729 | $5.21 | $19.4K | 1 |
| 2026-08-26 | Buy | Heltzen Michael | CEO | 505 | $7.48 | $3.8K | 3 |
| 2026-08-25 | Buy | Heltzen Michael | CEO | 350 | $7.51 | $2.6K | 2 |
| 2026-04-09 | Sell | Korman Tyler Paz | Other C-suite | 750 | $10.53 | $7.9K | 1 |
| 2026-04-08 | Sell | Korman Tyler Paz | Other C-suite | 750 | $10.04 | $7.5K | 1 |
| 2025-07-02 | Buy | Heltzen Michael | CEO | 1,040 | $10.22 | $10.6K | 1 |
| 2025-01-17 | Buy | Heltzen Michael | CEO | 1,767 | $10.78 | $19.0K | 1 |
| 2025-01-16 | Buy | Heltzen Michael | CEO | 121 | $10.72 | $1.3K | 1 |
| 2024-11-15 | Buy | Heltzen Michael | CEO | 1,984 | $11.10 | $22.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Heltzen Michael | CEO | $59.4K | $0 | 2026-08-26 |
| Perriman Damien Alan | Other C-suite | $0 | $19.4K | 2026-10-12 |
| Korman Tyler Paz | Other C-suite | $0 | $15.4K | 2026-04-09 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.